Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $67.5200 (-0.03%) ($66.8100 - $68.0300) on Thu. Aug. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.45% (three month average) | RSI | 59 | Latest Price | $67.5200(-0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 1.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) VYM(53%) DIA(52%) IVE(52%) SPLV(52%) | Factors Impacting ABBV price | ABBV will decline at least -1.225% in a week (0% probabilities). VIXM(-37%) VXX(-15%) TLT(-15%) IFRA(-13%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.225% (StdDev 2.45%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $66.49(1.55%) | 10 Day Moving Average | $65.47(3.13%) | 20 Day Moving Average | $65.68(2.8%) | To recent high | -17.2% | To recent low | 7.2% | Market Cap | $119.124b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |